Cinctive Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,462
Closed -$1.28M 436
2026
Q1
$1.28M Buy
+20,462
New +$1.64M 0.08% 238
2025
Q4
Sell
-13,254
Closed -$1.29M 400
2025
Q3
$1.29M Buy
+13,254
New +$1.37M 0.06% 284
2025
Q2
Sell
-103,559
Closed -$10.4M 378
2025
Q1
$10.4M Buy
+103,559
New +$10.4M 0.8% 28
2024
Q4
Sell
-175,563
Closed -$14.7M 362
2024
Q3
$14.7M Sell
175,563
-73,431
-29% -$5.79M 0.8% 27
2024
Q2
$19.2M Sell
248,994
-40,287
-14% -$2.95M 0.91% 20
2024
Q1
$19.8M Buy
289,281
+108,460
+60% +$6.97M 0.92% 25
2023
Q4
$10.5M Buy
+180,821
New +$9.65M 0.69% 33
2023
Q3
Sell
-237,146
Closed -$12.8M 372
2023
Q2
$12.8M Sell
237,146
-119,714
-34% -$6.25M 0.43% 66
2023
Q1
$17.9M Buy
356,860
+214,415
+151% +$10.1M 0.59% 37
2022
Q4
$6.59M Sell
142,445
-313,924
-69% -$13.6M 0.32% 94
2022
Q3
$17.7M Buy
456,369
+21,508
+5% +$863K 0.74% 17
2022
Q2
$16.2M Buy
434,861
+120,901
+39% +$4.92M 0.68% 17
2022
Q1
$13.9M Buy
313,960
+180,426
+135% +$7.82M 0.52% 39
2021
Q4
$5.67M Buy
+133,534
New +$5.61M 0.25% 129
2021
Q3
Sell
-141,932
Closed -$6.07M 545
2021
Q2
$6.07M Sell
141,932
-264,442
-65% -$11.1M 0.28% 106
2021
Q1
$15.7M Buy
+406,374
New +$15.4M 0.96% 7
2020
Q3
Sell
-99,769
Closed -$3.5M 293
2020
Q2
$3.5M Sell
99,769
-16,031
-14% -$577K 0.4% 97
2020
Q1
$3.78M Buy
115,800
+8,418
+8% +$329K 0.84% 34
2019
Q4
$4.86M Buy
+107,382
New +$4.49M 0.51% 91

Other funds holding BSX

Cinctive Capital Management's BSX Position: Q2 2026 in Review

Cinctive Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 20,462 shares — an estimated $1.28M sold.

Cinctive Capital Management first reported a position in BSX in Q4 2019 and held it in 19 quarters. The position peaked at $19.8M in Q1 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cinctive Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 20,462 Boston Scientific shares in Q2 2026, an estimated $1.28M.
  • Cinctive Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 19 quarters.
  • Cinctive Capital Management's Boston Scientific position peaked at $19.8M in Q1 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.